Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Emergent Biosolutions Inc - SIC # 2834 - PHARMACEUTICAL PREPARATIONS
Ticker
Exchange
SIC #
Website
Latest Ticker
EBS
New York
2834
https://emergentbiosolutions.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Emergent Biosolutions Inc
Q1 2024 Emergent BioSolutions Inc Earnings Call
- May 2nd, 2024 4:33 pm
Emergent BioSolutions Inc. (NYSE:EBS) Q1 2024 Earnings Call Transcript
- May 2nd, 2024 2:38 pm
Emergent BioSolutions Inc (EBS) (Q1 2024) Earnings Call Transcript Highlights: A Strong Start ...
- May 2nd, 2024 7:54 am
PRESS DIGEST- Wall Street Journal - May 2
- May 2nd, 2024 4:42 am
Emergent BioSolutions (EBS) Q1 2024 Earnings Call Transcript
- May 2nd, 2024 3:45 am
Emergent BioSolutions Reports Surprising Q1 2024 Earnings, Exceeding Revenue and Net Income ...
- May 1st, 2024 10:15 pm
Narcan-Maker Emergent BioSolutions to Cut 300 Jobs, Close Facilities
- May 1st, 2024 9:52 pm
Emergent BioSolutions Reports First Quarter 2024 Financial Results
- May 1st, 2024 8:57 pm
Emergent BioSolutions to lay off about 300 employees
- May 1st, 2024 8:38 pm
UPDATE 2-Emergent BioSolutions to lay off about 300 employees
- May 1st, 2024 8:34 pm
Emergent BioSolutions Announces Strategic Operational Changes to Stabilize Financial Position
- May 1st, 2024 8:10 pm
Emergent BioSolutions Releases New Survey Findings Underscoring the Need to Continue Expanding Access & Increasing Awareness to Naloxone
- May 1st, 2024 3:03 pm
Emergent BioSolutions Announces Amendment to its Existing Credit Facility
- Apr 30th, 2024 9:26 pm
Emergent BioSolutions to Release First Quarter 2024 Financial Results & Conduct Conference Call on May 1, 2024
- Apr 22nd, 2024 12:05 pm
Institutional owners may take dramatic actions as Emergent BioSolutions Inc.'s (NYSE:EBS) recent 16% drop adds to one-year losses
- Apr 17th, 2024 2:44 pm
Aquestive Therapeutics Strengthens Board of Directors with Experienced Biotech Executive
- Apr 1st, 2024 12:00 pm
Emergent BioSolutions Continues to Broaden Access, Awareness and Availability of NARCANĀ® Nasal Spray to Help Save Lives from the Ongoing Opioid Crisis
- Mar 28th, 2024 12:15 pm
Emergent BioSolutions Receives NAI Status for Baltimore Bayview Manufacturing Facility
- Mar 25th, 2024 12:05 pm
Emergent BioSolutions Inc (EBS) Reports Mixed Fourth Quarter and Full Year 2023 Financial Results
- Mar 7th, 2024 6:58 pm
Emergent (EBS) Down 16% on Q4 Earnings Miss, Tops on Sales
- Mar 7th, 2024 5:34 pm
Scroll